30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Wright Medical's BioMimetic subsidiary received FDA approval for its Premarket Approval Application for AUGMENT® Bone Graft. FDA has determined that AUGMENT is safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications. WMGI expects U.S. AUGMENT revenue in the range of US $10MM to $12MM within 7-8 months post-approval. (Wright Medical Technology, Inc., 9/1/15)